Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
Stocks making the biggest moves midday: PacWest, DraftKings, Pfizer, Foot Locker and more
May 22, 2023
From CNBC.com News
From CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
May 22, 2023
From CNBC.com News
From CNBC.com News
Cramer's Lightning Round:
May 18, 2023
From CNBC.com News
From CNBC.com News
A secretive annual meeting attended by the world's elite has disruptive A.I. top of the agenda
May 18, 2023
From CNBC.com News
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
May 17, 2023
From CNBC.com News
Stocks making the biggest moves midday: Horizon Therapeutics, Capital One, RH, Home Depot and more
May 16, 2023
Tickers
RH
From CNBC.com News
From CNBC.com News
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
May 16, 2023
From CNBC.com News
From CNBC.com News
Here's why Covid vaccines will still be free for uninsured Americans as public health emergency ends
May 12, 2023
From CNBC.com News
From CNBC.com News
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
May 09, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
April 18, 2023
From CNBC.com News
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systems
April 18, 2023
From CNBC.com News
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill
April 10, 2023
From CNBC.com News
Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
April 06, 2023
From CNBC.com News
From CNBC.com News
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
March 29, 2023
From CNBC.com News
BioNTech shares slip on gloomy Covid vaccine sales outlook
March 27, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.